Evidence map›Paper›PMID 41402481›Full record

ArticleMolecular psychiatry2026

Fshr gene depletion prevents recognition memory loss, fat accrual and bone loss in Alzheimer's mice.

Uliana Cheliadinova, Steven Sims, Funda Korkmaz, Darya Vasilyeva, Victoria Laurencin, Judit Gimenez-Roig, Georgii Pevnev, Guzel Burganova, Zehra Tumoglu, Surabhi Parte and 19 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Uliana Cheliadinova *Instuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID 0009-0007-2308-4824
Steven Sims *Instuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID 0000-0002-1636-084X
Funda KorkmazInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Darya VasilyevaInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Victoria LaurencinInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Judit Gimenez-RoigInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Georgii PevnevInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Guzel BurganovaInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID 0000-0002-7204-7268
Zehra TumogluInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Surabhi ParteInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Farhath SultanaInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Anusha R PallapatiInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Satish RojekarInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Anne MacdonaldInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Susan HutchisonInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Avi SoussanInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Anchine LiuInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Yi WeiInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Ofer MoldavskiInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Anisa GumerovaInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Weibin ZhouInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Orly BarakInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Ki A GoosensInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID 0000-0002-5246-2261
Vitaly RyuInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Daria LiznevaInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Clifford J RosenMaineHealth Institute for Research, Scarborough, ME, 04074, USA.
Tony YuenInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. tony.yuen@mssm.edu.ORCID 0009-0001-6000-8827
Tal FrolingerInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. tal.frolinger@mssm.edu.ORCID 0000-0002-2066-6649
Mone ZaidiInstuitute for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. mone.zaidi@mssm.edu.ORCID 0000-0001-5911-9522

Funding

Targeting FSH for the Therapy of Osteoporosis, Obesity and NeurodegenerationU19AG060917 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Daria Lizneva · 2019 to 2026
$29.0M
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's DiseaseU01AG073148 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Tony Yuen, Mone Zaidi · 2021 to 2026
$10.6M
Elevated FSH - A Driver for Sex Differences in Alzheimer's DiseaseR01AG074092 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HAROUTUNIAN, VAHRAM, YUEN, TONY · 2021 to 2025
$6.3M
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly FemalesR01AG071870 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KIM, SE-MIN, YUEN, TONY · 2021 to 2025
$3.9M
AAV-mediated Interrogation of the Brain FSH ReceptorR61AG094602 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GOOSENS, KI ANN, RYU, VITALY ANATOLIEVICH · 2025 to 2025
$2.1M
NIA NIH HHS R01 AG071870NIA NIH HHS R01 AG074092NIA NIH HHS R61 AG094602NIA NIH HHS RF1 AG093773NIA NIH HHS U01 AG073148NIA NIH HHS U19 AG060917
6 · The paper itself

Abstract

Epidemiologic evidence links follicle-stimulating hormone (FSH), a pituitary glycoprotein that rises during menopause, to memory loss, fat accumulation, and bone loss. We and others have shown that the attenuation of FSH signaling, either genetically or pharmacologically, prevents memory loss, fat accrual, and bone loss in multiple mouse models. Here, we investigated whether the genetic depletion of the FSH receptor (Fshr) affects recognition memory, body composition, and bone mineral density (BMD) in two AD mouse models. We generated male and female 3xTg and APP-KI mice carrying the Fshr

Indexed as

Alzheimer DiseaseMemory DisordersReceptors, FSHAdipose TissueAmyloid beta-Protein PrecursorAnimalsBody CompositionBone DensityDisease Models, AnimalFemaleFollicle Stimulating HormoneMaleMiceMice, Inbred C57BLMice, TransgenicRecognition, PsychologyAmyloid beta-Protein PrecursorFollicle Stimulating HormoneReceptors, FSH

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.